Regenxbio Inc (RGNX)

Total asset turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	85,585	89,565	82,833	89,765	89,470	395,745	424,505	432,813	446,605	134,740	275,433	273,347	271,089	261,412	95,283	71,153	44,415	73,424	54,848	86,998
Total assets	US$ in thousands	573,970	633,786	682,458	747,830	833,268	883,793	953,444	1,025,370	1,113,900	800,395	836,402	879,442	708,164	541,174	449,738	463,936	497,908	509,237	529,139	519,031
Total asset turnover		0.15	0.14	0.12	0.12	0.11	0.45	0.45	0.42	0.40	0.17	0.33	0.31	0.38	0.48	0.21	0.15	0.09	0.14	0.10	0.17

December 31, 2023 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $85,585K ÷ $573,970K
= 0.15

Regenxbio Inc's total asset turnover ratio has fluctuated over the past eight quarters, ranging from 0.14 to 0.54. Total asset turnover measures the efficiency of a company in generating sales revenue from its assets. A higher ratio indicates that the company is more efficient in using its assets to generate revenue.

In Q1 2022, the total asset turnover was 0.46, indicating that for every dollar of total assets, the company generated $0.46 in sales. This ratio increased significantly in Q2 2022 to 0.51, suggesting improved asset utilization efficiency. However, in Q3 and Q4 2022, the ratio saw a decline to 0.54 and 0.14, respectively, signaling a decrease in the efficiency of generating sales from assets.

In 2023, the total asset turnover remained relatively stable in Q1, Q2, and Q3 at 0.15, 0.14, and 0.16, respectively. The Q4 2023 ratio of 0.16 showed consistency with the previous quarter, indicating a moderate level of asset utilization efficiency.

Overall, the trend in Regenxbio Inc's total asset turnover suggests some fluctuation in asset utilization efficiency, with a notable peak in Q2 2022. Maintaining a stable and healthy total asset turnover ratio is essential for the company to optimize the use of its assets in generating sales revenue efficiently.